Dawaa Reference

chronic

Congenital Anomaly of the Neurological System

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources3 sources

ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class ND55 - condition scope only, no dose · No dose - referral pathway, no medicine given in primary care · Spina Bifida - StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK559265/

Verified against1 document
  • No dose - referral pathway, no medicine given in primary care

Verified date2026-08

1

NO DRUG THERAPY IN PRIMARY CARE (REFERRAL & ADVICE)

1st line
Adult dose and duration

Umbrella category for structural brain or spinal cord malformations present from birth (e.g. neural tube defects, hydrocephalus, cerebral malformations); the GP's role is early recognition and referral to paediatric neurology/neurosurgery, since management is specialist and often surgical. - Refer, with advice

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

Umbrella category for structural brain or spinal cord malformations present from birth (e.g. neural tube defects, hydrocephalus, cerebral malformations); the GP's role is early recognition and referral to paediatric neurology/neurosurgery, since management is specialist and often surgical.

Cautions
  • No medicine is prescribed for this in primary care - this entry is for recognition and referral. Anything given is decided by the service it is referred to.
  • RED FLAG - Abnormal head size or shape in an infant, developmental delay or regression, or signs of raised intracranial pressure such as a bulging fontanelle or sunsetting eyes: refer urgently.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.